SlideShare ist ein Scribd-Unternehmen logo
1 von 2
Downloaden Sie, um offline zu lesen
Journal of Cancer Epidemiology & Treatment
Shed a Light in the Darkness: Technology against Cancer
Fabiano Yokaichiya1
, Margareth Kazuyo Kobayashi Dias Franco2
, Tiago Rodrigues3
, Daniele Ribeiro de Araujo3
, Joachim Storsberg4
, Christian
Schmidt4*
1
Helmholtz-Zentrum Berlin für Materialien und Energie GmbH
2
Instituto de Pesquisas Energéticas e Nucleares
3
Universidade Federal do ABC
4
Fraunhofer-Institute Applied Polymer Research (IAP)
www.verizonaonlinepublishing.com
J Can Epi Treat 1(1). Page | 4
*Corresponding author: Christian Schmidt, PhD, Dept. of Polymers for Biomedical Engineering, Fraunhofer-Institute Applied Polymer
Research (IAP), GeiselbergstraBe 69, 14476 Potsdam-Golm, Germany, Tel: +49-331-568-1456; Fax: +49-331-568-3000;
E mail: christian.schmidt@iap.fraunhofer.de
Article Type: Editorial, Submission Date: 15 May 2015, Accepted Date: 10 June 2015, Published Date: 22 June 2015.
Citation: Fabiano Yokaichiya, Margareth Kazuyo Kobayashi Dias Franco, Tiago Rodrigues, Daniele Ribeiro de Araujo, Joachim Storsberg, et
al. (2015) Shed a Light in the Darkness: Technology against Cancer. J Can Epi Treat 1(1): 4-5.
Copyright: © 2015 Christian Schmidt, et al. This is an open-access article distributed under the terms of the Creative Commons Attribution
License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are
credited.
Vol: 1, Issue: 1
Abstract
Farfromthetimewhenasimplecandlelightilluminatedanoptical
microscope in an attempt to remove the veil of the unknown and
fascinating world of biological phenomena, we now live in a
world where stupendous research facilities are able to really shed
some light through the world of functioning of life. Although
the great discoveries have been carried out in the 50´s, with the
solution of the DNA model, and the first protein (myoglobin)
and enzyme (lysozyme) structures have been solved in the 60´s,
thanks to the advent of these facilities, synchrotron radiation and
neutron (reactors and spallation sources) laboratories, a huge
input in the life science has allowed the scientists to reveal the
mysterious of biochemical and biophysical processes of nature.
Discussion
Nowadays, more than a hundred thousand protein structures
(five to nine thousand per year in the last decade) has been
determined using the macromolecular crystallography (with
X-ray and neutron sources) and helped the researchers to
understand the complex circles of biochemical process inside
the human body. Furthermore, these findings have assisted the
scientific community to design drugs in order to attack specific
diseases, including several types of cancer. Not just the protein
crystallography, but the myriad of techniques, such as neutron
and X-ray small angle scattering, circular dichroism, imaging
techniques (X-ray and neutron tomography), infrared micro-
spectroscopyandinelasticneutronscattering,arebeingusedwith
the purpose of giving more details of the intricate biochemical
and biophysical cellular processes, like the protein-protein and
protein-lipid interaction, or the dynamical process of the drug in
a specific solution against its target. Although it is necessary not
just high initials investments to their implementations but also
high maintenance costs, countries like Brazil, Argentina, South
Africa, Australia, Russia, India and China, are aware of their
importance in the technological advances to the improvement
of the socioeconomic development, showing great interest in the
construction of big facilities. The aim to overcome the challenges
of scientific and technological development, we name Brazilian
case, where investment has been made for the construction of
two facilities for scientific development:
Brazilian Multipurpose Reactor - RMB and Light Synchrotron
Laboratory - Sirius. In despite of economic difficulties hundreds
of millions of dollar will be applied to support local and
international scientific community.
Inmedicalandpharmaceuticalpointofview,alltheseinformation
are essentials in the development of new and efficient drugs to
grapple with cancer and its complexity. Cancer cells present
several strategies to escape from cell death, to develop invasive
mechanisms, and to maintain a high proliferative rate, including
the modulation of gene expression, up- and down-regulation of
signaling pathways, among others. Continuous discoveries and
comprehension of such alterations allows further advances in the
understadingofcancerbiology,identificationofmoleculartargets
and improvement of cancer therapy. Therefore, the ways how to
send the drugs to the right target inside the body are also required
in order to get the maximum effectiveness and the minimum
side effects to the patient with cancer. For this reason, the deepen
of researches related to the “nanoworld” has enabled not only
the elucidation of the structure of biological macromolecules,
but also provided basis for the development of novel therapies
using nanocarriers systems such as liposomes, cyclodextrins,
nanocapsules, micelles, nanospheres, dendrimers, etc. In fact,
the analysis of their supramolecular structure, the study of their
interaction with drugs and/or other bioactive molecules has been
accomplished through physico-chemical techniques, allowing
the selection of the most appropriate systems for the targeted
therapy. Therefore, the Nanotechnology applied to Chemistry,
Pharmaceutical Technology, Pharmacology and Nanomedicine
using drug-delivery systems allied to the use of the large facilities
for their physico-chemical characterization will improve the
methods of production of those systems in order to facilitate and
optimize their action into the body.
J Can Epi Treat 1(1). Page | 5
Citation: Fabiano Yokaichiya, Margareth Kazuyo Kobayashi Dias Franco, Tiago Rodrigues, Daniele Ribeiro de Araujo, Joachim Storsberg, et al.
(2015) Shed a Light in the Darkness: Technology against Cancer. J Can Epi Treat 1(1): 4-5.
Conclusion
We believe that, with all the efforts and new technologies
developments, in a future, the war against cancer will be won,
thanks to the coalition of the several physical, chemical and
biologicaltechniques,withtheuseofadvancementofthepowerful
tools of technology. For the time being, we are overcoming the
battles.

Weitere ähnliche Inhalte

Was ist angesagt?

Use of Simulation- based Training for Cancer Education among Nigerian Clinicians
Use of Simulation- based Training for Cancer Education among Nigerian CliniciansUse of Simulation- based Training for Cancer Education among Nigerian Clinicians
Use of Simulation- based Training for Cancer Education among Nigerian Cliniciansasclepiuspdfs
 
Application of Biomedical Informatics in Clinical Problem Solving
Application of Biomedical Informatics in Clinical Problem SolvingApplication of Biomedical Informatics in Clinical Problem Solving
Application of Biomedical Informatics in Clinical Problem Solvingimprovemed
 
Nanotechnology for cancer therapy recent developments
Nanotechnology for cancer therapy recent developmentsNanotechnology for cancer therapy recent developments
Nanotechnology for cancer therapy recent developmentsroshan telrandhe
 
Missouri China Programme: Science Communication
Missouri China Programme: Science CommunicationMissouri China Programme: Science Communication
Missouri China Programme: Science CommunicationGlobal Plant Council
 
Dubina Michael biomedical technologies at Skolkovo
Dubina Michael biomedical technologies at SkolkovoDubina Michael biomedical technologies at Skolkovo
Dubina Michael biomedical technologies at Skolkovoigorod
 
Precision Oncology - using Genomics, Proteomics and Imaging to inform biology...
Precision Oncology - using Genomics, Proteomics and Imaging to inform biology...Precision Oncology - using Genomics, Proteomics and Imaging to inform biology...
Precision Oncology - using Genomics, Proteomics and Imaging to inform biology...Warren Kibbe
 
Big Data & Immunotherapeutics Symposium Program
Big Data & Immunotherapeutics Symposium ProgramBig Data & Immunotherapeutics Symposium Program
Big Data & Immunotherapeutics Symposium ProgramMichael Evtushenko
 
International Journal of Biometrics and Bioinformatics(IJBB) Volume (3) Issue...
International Journal of Biometrics and Bioinformatics(IJBB) Volume (3) Issue...International Journal of Biometrics and Bioinformatics(IJBB) Volume (3) Issue...
International Journal of Biometrics and Bioinformatics(IJBB) Volume (3) Issue...CSCJournals
 
Sonogenetic Locale Specific Activation of Universal Vectors for Xenobiotics -...
Sonogenetic Locale Specific Activation of Universal Vectors for Xenobiotics -...Sonogenetic Locale Specific Activation of Universal Vectors for Xenobiotics -...
Sonogenetic Locale Specific Activation of Universal Vectors for Xenobiotics -...Nejc Draganjec
 
Precision oncology ncabr kibbe oct 2017
Precision oncology ncabr kibbe oct 2017Precision oncology ncabr kibbe oct 2017
Precision oncology ncabr kibbe oct 2017Warren Kibbe
 
Chapter 1. Introduction
Chapter 1. IntroductionChapter 1. Introduction
Chapter 1. Introductionbutest
 

Was ist angesagt? (18)

Use of Simulation- based Training for Cancer Education among Nigerian Clinicians
Use of Simulation- based Training for Cancer Education among Nigerian CliniciansUse of Simulation- based Training for Cancer Education among Nigerian Clinicians
Use of Simulation- based Training for Cancer Education among Nigerian Clinicians
 
Dr. Obumneke Amadi-Onuoha -Transcript 37_ clinical trail design
Dr. Obumneke Amadi-Onuoha -Transcript 37_ clinical trail designDr. Obumneke Amadi-Onuoha -Transcript 37_ clinical trail design
Dr. Obumneke Amadi-Onuoha -Transcript 37_ clinical trail design
 
Journal of Cancer Science & Research
Journal of Cancer Science & ResearchJournal of Cancer Science & Research
Journal of Cancer Science & Research
 
Application of Biomedical Informatics in Clinical Problem Solving
Application of Biomedical Informatics in Clinical Problem SolvingApplication of Biomedical Informatics in Clinical Problem Solving
Application of Biomedical Informatics in Clinical Problem Solving
 
Bio informatics
Bio informaticsBio informatics
Bio informatics
 
Nanotechnology for cancer therapy recent developments
Nanotechnology for cancer therapy recent developmentsNanotechnology for cancer therapy recent developments
Nanotechnology for cancer therapy recent developments
 
Missouri China Programme: Science Communication
Missouri China Programme: Science CommunicationMissouri China Programme: Science Communication
Missouri China Programme: Science Communication
 
Dubina Michael biomedical technologies at Skolkovo
Dubina Michael biomedical technologies at SkolkovoDubina Michael biomedical technologies at Skolkovo
Dubina Michael biomedical technologies at Skolkovo
 
CV
CVCV
CV
 
Precision Oncology - using Genomics, Proteomics and Imaging to inform biology...
Precision Oncology - using Genomics, Proteomics and Imaging to inform biology...Precision Oncology - using Genomics, Proteomics and Imaging to inform biology...
Precision Oncology - using Genomics, Proteomics and Imaging to inform biology...
 
Big Data & Immunotherapeutics Symposium Program
Big Data & Immunotherapeutics Symposium ProgramBig Data & Immunotherapeutics Symposium Program
Big Data & Immunotherapeutics Symposium Program
 
bioph Abstract
bioph Abstractbioph Abstract
bioph Abstract
 
International Journal of Biometrics and Bioinformatics(IJBB) Volume (3) Issue...
International Journal of Biometrics and Bioinformatics(IJBB) Volume (3) Issue...International Journal of Biometrics and Bioinformatics(IJBB) Volume (3) Issue...
International Journal of Biometrics and Bioinformatics(IJBB) Volume (3) Issue...
 
Sonogenetic Locale Specific Activation of Universal Vectors for Xenobiotics -...
Sonogenetic Locale Specific Activation of Universal Vectors for Xenobiotics -...Sonogenetic Locale Specific Activation of Universal Vectors for Xenobiotics -...
Sonogenetic Locale Specific Activation of Universal Vectors for Xenobiotics -...
 
Precision oncology ncabr kibbe oct 2017
Precision oncology ncabr kibbe oct 2017Precision oncology ncabr kibbe oct 2017
Precision oncology ncabr kibbe oct 2017
 
Tteh.000542
Tteh.000542Tteh.000542
Tteh.000542
 
Oncology
OncologyOncology
Oncology
 
Chapter 1. Introduction
Chapter 1. IntroductionChapter 1. Introduction
Chapter 1. Introduction
 

Ähnlich wie JournalofCancerEpidemiologyandTreatment3

Ultrasound Technology as a Novel Treatment Strategy in Pancreatic Cancer_Crim...
Ultrasound Technology as a Novel Treatment Strategy in Pancreatic Cancer_Crim...Ultrasound Technology as a Novel Treatment Strategy in Pancreatic Cancer_Crim...
Ultrasound Technology as a Novel Treatment Strategy in Pancreatic Cancer_Crim...CrimsonpublishersCancer
 
Improvisation of Conventional Techniques: The Future of Oncology Research
Improvisation of Conventional Techniques: The Future of Oncology ResearchImprovisation of Conventional Techniques: The Future of Oncology Research
Improvisation of Conventional Techniques: The Future of Oncology Researchasclepiuspdfs
 
Application of Microarray Technology and softcomputing in cancer Biology
Application of Microarray Technology and softcomputing in cancer BiologyApplication of Microarray Technology and softcomputing in cancer Biology
Application of Microarray Technology and softcomputing in cancer BiologyCSCJournals
 
application_of_bioinformatics_in_various_fields.ppt
application_of_bioinformatics_in_various_fields.pptapplication_of_bioinformatics_in_various_fields.ppt
application_of_bioinformatics_in_various_fields.pptshankjunk
 
application_of_bioinformatics_in_various_fields.ppt
application_of_bioinformatics_in_various_fields.pptapplication_of_bioinformatics_in_various_fields.ppt
application_of_bioinformatics_in_various_fields.pptshankjunk
 
NANOTECHNOLOGY FOR CANCER THERAPY RECENT DEVELOPMENTS
NANOTECHNOLOGY FOR CANCER THERAPY RECENT DEVELOPMENTSNANOTECHNOLOGY FOR CANCER THERAPY RECENT DEVELOPMENTS
NANOTECHNOLOGY FOR CANCER THERAPY RECENT DEVELOPMENTSroshan telrandhe
 
Introduction to cancer bioinformatics
Introduction to cancer bioinformaticsIntroduction to cancer bioinformatics
Introduction to cancer bioinformaticscreativebiolabs11
 
2nd Epigenetics Discovery congress - Latest agenda
2nd Epigenetics Discovery congress - Latest agenda2nd Epigenetics Discovery congress - Latest agenda
2nd Epigenetics Discovery congress - Latest agendaTony Couch
 
ciclo autonomico-short paper - Witfor 2016 paper_42
ciclo autonomico-short paper - Witfor 2016 paper_42ciclo autonomico-short paper - Witfor 2016 paper_42
ciclo autonomico-short paper - Witfor 2016 paper_42.. ..
 
application of nanoparticles in the early diagnosis and treatment of tumors: ...
application of nanoparticles in the early diagnosis and treatment of tumors: ...application of nanoparticles in the early diagnosis and treatment of tumors: ...
application of nanoparticles in the early diagnosis and treatment of tumors: ...LucyPi1
 
Central mucoepidermoid carcinoma an up to-date analysis of 147 cases
Central mucoepidermoid carcinoma an up to-date analysis of 147 casesCentral mucoepidermoid carcinoma an up to-date analysis of 147 cases
Central mucoepidermoid carcinoma an up to-date analysis of 147 casesMNTan1
 
The Significance of Lifescience- An In-depth Exploration.pdf
The Significance of Lifescience- An In-depth Exploration.pdfThe Significance of Lifescience- An In-depth Exploration.pdf
The Significance of Lifescience- An In-depth Exploration.pdfhealthcare360social
 
cancers-03-03279-v2.pdf
cancers-03-03279-v2.pdfcancers-03-03279-v2.pdf
cancers-03-03279-v2.pdfTajuddin Shaik
 
Next Generation Sequencing in Detecting Oral Cancer Due to Tobacco Consumption
Next Generation Sequencing in Detecting Oral Cancer Due to Tobacco ConsumptionNext Generation Sequencing in Detecting Oral Cancer Due to Tobacco Consumption
Next Generation Sequencing in Detecting Oral Cancer Due to Tobacco Consumptionbioejjournal
 
NEXT GENERATION SEQUENCING IN DETECTING ORAL CANCER DUE TO TOBACCO CONSUMPTION
NEXT GENERATION SEQUENCING IN DETECTING ORAL CANCER DUE TO TOBACCO CONSUMPTIONNEXT GENERATION SEQUENCING IN DETECTING ORAL CANCER DUE TO TOBACCO CONSUMPTION
NEXT GENERATION SEQUENCING IN DETECTING ORAL CANCER DUE TO TOBACCO CONSUMPTIONbioejjournal
 
Perspective: Imaging for Gliomas
Perspective: Imaging for GliomasPerspective: Imaging for Gliomas
Perspective: Imaging for Gliomasasclepiuspdfs
 

Ähnlich wie JournalofCancerEpidemiologyandTreatment3 (20)

Ultrasound Technology as a Novel Treatment Strategy in Pancreatic Cancer_Crim...
Ultrasound Technology as a Novel Treatment Strategy in Pancreatic Cancer_Crim...Ultrasound Technology as a Novel Treatment Strategy in Pancreatic Cancer_Crim...
Ultrasound Technology as a Novel Treatment Strategy in Pancreatic Cancer_Crim...
 
Improvisation of Conventional Techniques: The Future of Oncology Research
Improvisation of Conventional Techniques: The Future of Oncology ResearchImprovisation of Conventional Techniques: The Future of Oncology Research
Improvisation of Conventional Techniques: The Future of Oncology Research
 
Application of Microarray Technology and softcomputing in cancer Biology
Application of Microarray Technology and softcomputing in cancer BiologyApplication of Microarray Technology and softcomputing in cancer Biology
Application of Microarray Technology and softcomputing in cancer Biology
 
application_of_bioinformatics_in_various_fields.ppt
application_of_bioinformatics_in_various_fields.pptapplication_of_bioinformatics_in_various_fields.ppt
application_of_bioinformatics_in_various_fields.ppt
 
application_of_bioinformatics_in_various_fields.ppt
application_of_bioinformatics_in_various_fields.pptapplication_of_bioinformatics_in_various_fields.ppt
application_of_bioinformatics_in_various_fields.ppt
 
NANOTECHNOLOGY FOR CANCER THERAPY RECENT DEVELOPMENTS
NANOTECHNOLOGY FOR CANCER THERAPY RECENT DEVELOPMENTSNANOTECHNOLOGY FOR CANCER THERAPY RECENT DEVELOPMENTS
NANOTECHNOLOGY FOR CANCER THERAPY RECENT DEVELOPMENTS
 
Introduction to cancer bioinformatics
Introduction to cancer bioinformaticsIntroduction to cancer bioinformatics
Introduction to cancer bioinformatics
 
2nd Epigenetics Discovery congress - Latest agenda
2nd Epigenetics Discovery congress - Latest agenda2nd Epigenetics Discovery congress - Latest agenda
2nd Epigenetics Discovery congress - Latest agenda
 
Plegable biología 1
Plegable biología 1Plegable biología 1
Plegable biología 1
 
ciclo autonomico-short paper - Witfor 2016 paper_42
ciclo autonomico-short paper - Witfor 2016 paper_42ciclo autonomico-short paper - Witfor 2016 paper_42
ciclo autonomico-short paper - Witfor 2016 paper_42
 
application of nanoparticles in the early diagnosis and treatment of tumors: ...
application of nanoparticles in the early diagnosis and treatment of tumors: ...application of nanoparticles in the early diagnosis and treatment of tumors: ...
application of nanoparticles in the early diagnosis and treatment of tumors: ...
 
Central mucoepidermoid carcinoma an up to-date analysis of 147 cases
Central mucoepidermoid carcinoma an up to-date analysis of 147 casesCentral mucoepidermoid carcinoma an up to-date analysis of 147 cases
Central mucoepidermoid carcinoma an up to-date analysis of 147 cases
 
Report[1]
Report[1]Report[1]
Report[1]
 
The Significance of Lifescience- An In-depth Exploration.pdf
The Significance of Lifescience- An In-depth Exploration.pdfThe Significance of Lifescience- An In-depth Exploration.pdf
The Significance of Lifescience- An In-depth Exploration.pdf
 
cancers-03-03279-v2.pdf
cancers-03-03279-v2.pdfcancers-03-03279-v2.pdf
cancers-03-03279-v2.pdf
 
Next Generation Sequencing in Detecting Oral Cancer Due to Tobacco Consumption
Next Generation Sequencing in Detecting Oral Cancer Due to Tobacco ConsumptionNext Generation Sequencing in Detecting Oral Cancer Due to Tobacco Consumption
Next Generation Sequencing in Detecting Oral Cancer Due to Tobacco Consumption
 
NEXT GENERATION SEQUENCING IN DETECTING ORAL CANCER DUE TO TOBACCO CONSUMPTION
NEXT GENERATION SEQUENCING IN DETECTING ORAL CANCER DUE TO TOBACCO CONSUMPTIONNEXT GENERATION SEQUENCING IN DETECTING ORAL CANCER DUE TO TOBACCO CONSUMPTION
NEXT GENERATION SEQUENCING IN DETECTING ORAL CANCER DUE TO TOBACCO CONSUMPTION
 
JALANov2000
JALANov2000JALANov2000
JALANov2000
 
s12951-020-00613-6.pdf
s12951-020-00613-6.pdfs12951-020-00613-6.pdf
s12951-020-00613-6.pdf
 
Perspective: Imaging for Gliomas
Perspective: Imaging for GliomasPerspective: Imaging for Gliomas
Perspective: Imaging for Gliomas
 

Mehr von Christian Schmidt (20)

ofsp.10792
ofsp.10792ofsp.10792
ofsp.10792
 
ofsp.10744
ofsp.10744ofsp.10744
ofsp.10744
 
biomedicines-04-00022
biomedicines-04-00022biomedicines-04-00022
biomedicines-04-00022
 
ofsp.10693
ofsp.10693ofsp.10693
ofsp.10693
 
schmidt-2016
schmidt-2016schmidt-2016
schmidt-2016
 
the-sins-of-omission-v8tq
the-sins-of-omission-v8tqthe-sins-of-omission-v8tq
the-sins-of-omission-v8tq
 
1-s2.0-S1818087615001221-main
1-s2.0-S1818087615001221-main1-s2.0-S1818087615001221-main
1-s2.0-S1818087615001221-main
 
relating-the-pendulum-of-democracy-with-oncology-research-1eSo
relating-the-pendulum-of-democracy-with-oncology-research-1eSorelating-the-pendulum-of-democracy-with-oncology-research-1eSo
relating-the-pendulum-of-democracy-with-oncology-research-1eSo
 
JournalofCancerEpidemiologyandTreatment6
JournalofCancerEpidemiologyandTreatment6JournalofCancerEpidemiologyandTreatment6
JournalofCancerEpidemiologyandTreatment6
 
JournalofCancerEpidemiologyandTreatment2
JournalofCancerEpidemiologyandTreatment2JournalofCancerEpidemiologyandTreatment2
JournalofCancerEpidemiologyandTreatment2
 
JournalofCancerEpidemiologyandTreatment1
JournalofCancerEpidemiologyandTreatment1JournalofCancerEpidemiologyandTreatment1
JournalofCancerEpidemiologyandTreatment1
 
jbc1998
jbc1998jbc1998
jbc1998
 
schmidt2003
schmidt2003schmidt2003
schmidt2003
 
emboj200920a
emboj200920aemboj200920a
emboj200920a
 
1476-4598-7-86
1476-4598-7-861476-4598-7-86
1476-4598-7-86
 
1476-4598-7-63
1476-4598-7-631476-4598-7-63
1476-4598-7-63
 
1476-4598-7-18
1476-4598-7-181476-4598-7-18
1476-4598-7-18
 
1476-4598-6-43
1476-4598-6-431476-4598-6-43
1476-4598-6-43
 
1476-4598-3-23
1476-4598-3-231476-4598-3-23
1476-4598-3-23
 
1476-4598-2-26
1476-4598-2-261476-4598-2-26
1476-4598-2-26
 

JournalofCancerEpidemiologyandTreatment3

  • 1. Journal of Cancer Epidemiology & Treatment Shed a Light in the Darkness: Technology against Cancer Fabiano Yokaichiya1 , Margareth Kazuyo Kobayashi Dias Franco2 , Tiago Rodrigues3 , Daniele Ribeiro de Araujo3 , Joachim Storsberg4 , Christian Schmidt4* 1 Helmholtz-Zentrum Berlin für Materialien und Energie GmbH 2 Instituto de Pesquisas Energéticas e Nucleares 3 Universidade Federal do ABC 4 Fraunhofer-Institute Applied Polymer Research (IAP) www.verizonaonlinepublishing.com J Can Epi Treat 1(1). Page | 4 *Corresponding author: Christian Schmidt, PhD, Dept. of Polymers for Biomedical Engineering, Fraunhofer-Institute Applied Polymer Research (IAP), GeiselbergstraBe 69, 14476 Potsdam-Golm, Germany, Tel: +49-331-568-1456; Fax: +49-331-568-3000; E mail: christian.schmidt@iap.fraunhofer.de Article Type: Editorial, Submission Date: 15 May 2015, Accepted Date: 10 June 2015, Published Date: 22 June 2015. Citation: Fabiano Yokaichiya, Margareth Kazuyo Kobayashi Dias Franco, Tiago Rodrigues, Daniele Ribeiro de Araujo, Joachim Storsberg, et al. (2015) Shed a Light in the Darkness: Technology against Cancer. J Can Epi Treat 1(1): 4-5. Copyright: © 2015 Christian Schmidt, et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. Vol: 1, Issue: 1 Abstract Farfromthetimewhenasimplecandlelightilluminatedanoptical microscope in an attempt to remove the veil of the unknown and fascinating world of biological phenomena, we now live in a world where stupendous research facilities are able to really shed some light through the world of functioning of life. Although the great discoveries have been carried out in the 50´s, with the solution of the DNA model, and the first protein (myoglobin) and enzyme (lysozyme) structures have been solved in the 60´s, thanks to the advent of these facilities, synchrotron radiation and neutron (reactors and spallation sources) laboratories, a huge input in the life science has allowed the scientists to reveal the mysterious of biochemical and biophysical processes of nature. Discussion Nowadays, more than a hundred thousand protein structures (five to nine thousand per year in the last decade) has been determined using the macromolecular crystallography (with X-ray and neutron sources) and helped the researchers to understand the complex circles of biochemical process inside the human body. Furthermore, these findings have assisted the scientific community to design drugs in order to attack specific diseases, including several types of cancer. Not just the protein crystallography, but the myriad of techniques, such as neutron and X-ray small angle scattering, circular dichroism, imaging techniques (X-ray and neutron tomography), infrared micro- spectroscopyandinelasticneutronscattering,arebeingusedwith the purpose of giving more details of the intricate biochemical and biophysical cellular processes, like the protein-protein and protein-lipid interaction, or the dynamical process of the drug in a specific solution against its target. Although it is necessary not just high initials investments to their implementations but also high maintenance costs, countries like Brazil, Argentina, South Africa, Australia, Russia, India and China, are aware of their importance in the technological advances to the improvement of the socioeconomic development, showing great interest in the construction of big facilities. The aim to overcome the challenges of scientific and technological development, we name Brazilian case, where investment has been made for the construction of two facilities for scientific development: Brazilian Multipurpose Reactor - RMB and Light Synchrotron Laboratory - Sirius. In despite of economic difficulties hundreds of millions of dollar will be applied to support local and international scientific community. Inmedicalandpharmaceuticalpointofview,alltheseinformation are essentials in the development of new and efficient drugs to grapple with cancer and its complexity. Cancer cells present several strategies to escape from cell death, to develop invasive mechanisms, and to maintain a high proliferative rate, including the modulation of gene expression, up- and down-regulation of signaling pathways, among others. Continuous discoveries and comprehension of such alterations allows further advances in the understadingofcancerbiology,identificationofmoleculartargets and improvement of cancer therapy. Therefore, the ways how to send the drugs to the right target inside the body are also required in order to get the maximum effectiveness and the minimum side effects to the patient with cancer. For this reason, the deepen of researches related to the “nanoworld” has enabled not only the elucidation of the structure of biological macromolecules, but also provided basis for the development of novel therapies using nanocarriers systems such as liposomes, cyclodextrins, nanocapsules, micelles, nanospheres, dendrimers, etc. In fact, the analysis of their supramolecular structure, the study of their interaction with drugs and/or other bioactive molecules has been accomplished through physico-chemical techniques, allowing the selection of the most appropriate systems for the targeted therapy. Therefore, the Nanotechnology applied to Chemistry, Pharmaceutical Technology, Pharmacology and Nanomedicine using drug-delivery systems allied to the use of the large facilities for their physico-chemical characterization will improve the methods of production of those systems in order to facilitate and optimize their action into the body.
  • 2. J Can Epi Treat 1(1). Page | 5 Citation: Fabiano Yokaichiya, Margareth Kazuyo Kobayashi Dias Franco, Tiago Rodrigues, Daniele Ribeiro de Araujo, Joachim Storsberg, et al. (2015) Shed a Light in the Darkness: Technology against Cancer. J Can Epi Treat 1(1): 4-5. Conclusion We believe that, with all the efforts and new technologies developments, in a future, the war against cancer will be won, thanks to the coalition of the several physical, chemical and biologicaltechniques,withtheuseofadvancementofthepowerful tools of technology. For the time being, we are overcoming the battles.